Eddit

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
K
Zeile 3: Zeile 3:
 
*'''[[Unproven ideas]]'''
 
*'''[[Unproven ideas]]'''
 
*'''[[Reviews on covid19 disease]]'''
 
*'''[[Reviews on covid19 disease]]'''
 +
{{tp|p=32337143|t=ä. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update |pdf=|usr=}}
 +
{{tp|p=32337113|t=ä. Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2 |pdf=|usr=}}
 +
{{tp|p=32328367|t=ä. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment |pdf=|usr=}}
 +
{{tp|p=32300496|t=ä. Coronavirus Disease: A Review of a New Threat to Public Health |pdf=|usr=}}
 +
{{tp|p=32269893|t=ä. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32363221|t=ä. An overview of coronaviruses including the SARS-2 coronavirus ? Molecular biology, epidemiology and clinical implications |pdf=|usr=}}
  
 +
*'''[[Research tools]]'''
 +
{{tp|p=32142596|t=2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS |pdf=|usr=}}
 +
{{tp|p=32187834|t=2020. ..COVID19: Cytometry and the New Challenge for Global Health |pdf=|usr=}}
  
 
*'''[[Research tools]]'''
 
 
*
 
*
 
*'''[[Structure of covid19]]'''
 
*'''[[Structure of covid19]]'''
Zeile 49: Zeile 56:
 
{{tp|p=32271373|t=ä. Predictors of refractory Coronavirus disease (COVID-19) pneumonia |pdf=|usr=}}
 
{{tp|p=32271373|t=ä. Predictors of refractory Coronavirus disease (COVID-19) pneumonia |pdf=|usr=}}
 
{{tp|p=32375845|t=2020. Acute respiratory failure in COVID-19: is it ?typical? ARDS?|pdf=|usr=}}
 
{{tp|p=32375845|t=2020. Acute respiratory failure in COVID-19: is it ?typical? ARDS?|pdf=|usr=}}
 +
{{tp|p=32299472|t=2020. COVID-19 pneumonia: ARDS or not?|pdf=|usr=}}
 +
{{tp|p=32351860|t=ä. Coronavirus Disease 2019 (COVID-19) Complicated by Acute Respiratory Distress Syndrome: An Internist?s Perspective |pdf=|usr=}}
  
  
Zeile 61: Zeile 70:
 
{{tp|p=32371557|t=2020. SARS-CoV-2 and myocardial injury: Few answers, many questions |pdf=|usr=}}
 
{{tp|p=32371557|t=2020. SARS-CoV-2 and myocardial injury: Few answers, many questions |pdf=|usr=}}
 
{{tp|p=32331780|t=ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging |pdf=|usr=}}
 
{{tp|p=32331780|t=ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging |pdf=|usr=}}
 +
{{tp|p=32318865|t=2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response |pdf=|usr=}}
 +
  
 
*'''[[Neurology, ophthalmology, orl]]'''
 
*'''[[Neurology, ophthalmology, orl]]'''
Zeile 68: Zeile 79:
 
{{tp|p=32266761|t=2020. Neurological manifestations in COVID19 caused by SARS-CoV?2 |pdf=|usr=}}
 
{{tp|p=32266761|t=2020. Neurological manifestations in COVID19 caused by SARS-CoV?2 |pdf=|usr=}}
 
{{tp|p=32354654|t=ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic |pdf=|usr=}}
 
{{tp|p=32354654|t=ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic |pdf=|usr=}}
 +
{{tp|p=32328364|t=ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy |pdf=|usr=}}
 +
  
 
*'''[[Dermatology]]'''
 
*'''[[Dermatology]]'''
Zeile 75: Zeile 88:
 
{{tp|p=32305249|t=ä. A case of COVID-19 patient with the diarrhea as initial symptom and literature review |pdf=|usr=}}
 
{{tp|p=32305249|t=ä. A case of COVID-19 patient with the diarrhea as initial symptom and literature review |pdf=|usr=}}
 
{{tp|p=32366282|t=2020. Liver injury in critically ill patients with COVID-19: a case series |pdf=|usr=}}
 
{{tp|p=32366282|t=2020. Liver injury in critically ill patients with COVID-19: a case series |pdf=|usr=}}
 
+
{{tp|p=32351807|t=ä. Gastrointestinal Infection Could Be New Focus for Coronavirus Diagnosis |pdf=|usr=}}
  
 
*'''[[Kidney, urology]]==
 
*'''[[Kidney, urology]]==
 +
{{tp|p=32299479|t=2020. Acute kidney injury in SARS-CoV-2 infected patients |pdf=|usr=}}
 +
 
*
 
*
 
*'''[[Pathobiology]]'''
 
*'''[[Pathobiology]]'''
Zeile 87: Zeile 102:
 
*
 
*
 
*'''[[Diagnosis (Laboratory)]]'''
 
*'''[[Diagnosis (Laboratory)]]'''
 +
{{tp|p=32326952|t=2020. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression |pdf=|usr=}}
 +
{{tp|p=32313785|t=ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19 |pdf=|usr=}}
  
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
Zeile 97: Zeile 114:
 
{{tp|p=32234724|t=2020. Lung ultrasound findings in a 64-year-old woman with COVID-19 |pdf=|usr=}}
 
{{tp|p=32234724|t=2020. Lung ultrasound findings in a 64-year-old woman with COVID-19 |pdf=|usr=}}
 
{{tp|p=32345353|t=2020. Lung ultrasound findings in patients with COVID-19 pneumonia |pdf=|usr=}}
 
{{tp|p=32345353|t=2020. Lung ultrasound findings in patients with COVID-19 pneumonia |pdf=|usr=}}
 +
{{tp|p=32351814|t=ä. Common CT Findings of Novel Coronavirus Disease 2019 (COVID-19): A Case Series |pdf=|usr=}}
 +
{{tp|p=32305134|t=ä. Chest Imaging in Patients Hospitalized With COVID-19 Infection - A Case Series |pdf=|usr=}}
  
 +
*'''[[Diagnosis (other modalities)]]'''
 +
{{tp|p=32276598|t=2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia |pdf=|usr=}}
  
 
*'''[[Diagnosis (other modalities)]]'''
 
 
*'''[[Clinical guidelines and advice]]'''
 
*'''[[Clinical guidelines and advice]]'''
 
{{tp|p=32360444|t=ä. Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of anti-infective therapy (SITA) and the Italian Society of Pulmonology (SIP) |pdf=|usr=}}
 
{{tp|p=32360444|t=ä. Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of anti-infective therapy (SITA) and the Italian Society of Pulmonology (SIP) |pdf=|usr=}}
Zeile 115: Zeile 134:
 
{{tp|p=32188482|t=2020. COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China |pdf=|usr=}}
 
{{tp|p=32188482|t=2020. COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China |pdf=|usr=}}
 
{{tp|p=32151274|t=2020. Preparing for COVID-19: early experience from an intensive care unit in Singapore |pdf=|usr=}}
 
{{tp|p=32151274|t=2020. Preparing for COVID-19: early experience from an intensive care unit in Singapore |pdf=|usr=}}
 +
{{tp|p=32224769|t=2020. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults  with Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32257728|t=ä. Coronavirus Disease (COVID-19) and Pediatric Patients: A Review of Epidemiology,  Symptomatology, Laboratory and Imaging Results to Guide the Development of a Management Algorithm |pdf=|usr=}}
 +
  
 
*'''[[Respiration mgmt]]'''
 
*'''[[Respiration mgmt]]'''
 
{{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}}
 
{{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}}
 
{{tp|p=32357995|t=2020. Tracheal intubation in patients with COVID-19 |pdf=|usr=}}
 
{{tp|p=32357995|t=2020. Tracheal intubation in patients with COVID-19 |pdf=|usr=}}
 +
{{tp|p=32326959|t=2020. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients |pdf=|usr=}}
 +
{{tp|p=C7156900|t=2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series |pdf=|usr=}}
  
  
Zeile 130: Zeile 154:
 
{{tp|p=32332038|t=2020. Asthma and COVID-19 |pdf=|usr=}}
 
{{tp|p=32332038|t=2020. Asthma and COVID-19 |pdf=|usr=}}
 
{{tp|p=32264922|t=2020. COVID-19 and the RAAS?a potential role for angiotensin II?|pdf=|usr=}}
 
{{tp|p=32264922|t=2020. COVID-19 and the RAAS?a potential role for angiotensin II?|pdf=|usr=}}
 +
{{tp|p=32291526|t=2020. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB |pdf=|usr=}}
 +
{{tp|p=32350632|t=2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty |pdf=|usr=}}
 +
{{tp|p=32219626|t=ä. Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital, China |pdf=|usr=}}
  
  
Zeile 140: Zeile 167:
 
{{tp|p=32332041|t=2020. SARS-CoV-2 infection in a 76-year-old man with negative results for nasopharyngeal swabs and possible nosocomial transmission |pdf=|usr=}}
 
{{tp|p=32332041|t=2020. SARS-CoV-2 infection in a 76-year-old man with negative results for nasopharyngeal swabs and possible nosocomial transmission |pdf=|usr=}}
 
{{tp|p=32317275|t=2020. SARS-CoV-2 infection associated with spontaneous pneumothorax |pdf=|usr=}}
 
{{tp|p=32317275|t=2020. SARS-CoV-2 infection associated with spontaneous pneumothorax |pdf=|usr=}}
 +
{{tp|p=32337148|t=ä. Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial  Infarction |pdf=|usr=}}
 +
  
  
Zeile 149: Zeile 178:
 
{{tp|p=32375850|t=2020. Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan |pdf=|usr=}}
 
{{tp|p=32375850|t=2020. Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan |pdf=|usr=}}
 
{{tp|p=32354360|t=2020. Clinical course and outcome of 107 patients infected with the novel coronavirus,  SARS-CoV-2, discharged from two hospitals in Wuhan, China |pdf=|usr=}}
 
{{tp|p=32354360|t=2020. Clinical course and outcome of 107 patients infected with the novel coronavirus,  SARS-CoV-2, discharged from two hospitals in Wuhan, China |pdf=|usr=}}
 
+
{{tp|p=32232652|t=ä. Clinical and Transmission Characteristics of Covid-19 ? A Retrospective Study of  25 Cases from a Single Thoracic Surgery Department |pdf=|usr=}}
 
+
{{tp|p=32207032|t=ä. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China |pdf=|usr=}}
 
*
 
*
 
*'''[[Trials]]'''
 
*'''[[Trials]]'''
Zeile 165: Zeile 194:
 
{{tp|p=32280433|t=ä. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model |pdf=|usr=}}
 
{{tp|p=32280433|t=ä. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model |pdf=|usr=}}
 
{{tp|p=32345336|t=2020. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32345336|t=2020. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2 |pdf=|usr=}}
 
+
{{tp|p=32351851|t=ä. A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine |pdf=|usr=}}
 +
{{tp|p=32241301|t=2020. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19 |pdf=|usr=}}
 +
{{tp|p=32226695|t=ä. Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32318324|t=ä. Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival |pdf=|usr=}}
 +
{{tp|p=32340837|t=ä. Hydroxychloroquine in Covid-19: Does the end justify the means?|pdf=|usr=}}
 +
{{tp|p=32219057|t=ä. The SARS-CoV-2 Vaccine Pipeline: an Overview |pdf=|usr=}}
 +
{{tp|p=32360420|t=ä. Cytokine storm intervention in the early stages of COVID-19 pneumonia |pdf=|usr=}}
  
  
Zeile 223: Zeile 258:
 
{{tp|p=32345343|t=2020. COVID-19: ICU delirium management during SARS-CoV-2 pandemic |pdf=|usr=}}
 
{{tp|p=32345343|t=2020. COVID-19: ICU delirium management during SARS-CoV-2 pandemic |pdf=|usr=}}
 
{{tp|p=32345359|t=2020. The role of telemedicine during the COVID-19 epidemic in China?experience from Shandong province |pdf=|usr=}}
 
{{tp|p=32345359|t=2020. The role of telemedicine during the COVID-19 epidemic in China?experience from Shandong province |pdf=|usr=}}
 +
{{tp|p=32321566|t=2020. Managing COVID-19 in resource-limited settings: critical care considerations |pdf=|usr=}}
 +
{{tp|p=32229766|t=2020. COVID-19 Pandemic and Acute Myocardial Infarction: Management Protocol From a British Cardiac Centre |pdf=|usr=}}
 +
{{tp|p=32349045|t=2020. COVID-19 Pandemic and Cardiac Electrophysiology: Guidance Protocol From a UK Tertiary Cardiac Center |pdf=|usr=}}
 +
{{tp|p=C7155152|t=2020. How to transform a general hospital into an ?infectious disease hospital? during  the epidemic of COVID-19 |pdf=|usr=}}
 +
{{tp|p=32321562|t=2020. Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic |pdf=|usr=}}
 +
{{tp|p=32324622|t=2020. Restructuring Electrophysiology During the COVID-19 Pandemic: A Practical Guide From a New York City Hospital Network |pdf=|usr=}}
 +
{{tp|p=32344317|t=ä. Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence |pdf=|usr=}}
 +
{{tp|p=32368424|t=ä. The Impact of COVID-19 on Medical Education |pdf=|usr=}}
 +
{{tp|p=32368429|t=ä. Quantifying the Impact of COVID-19 on Cancer Patients: A Technical Report of Patient Experience During the COVID-19 Pandemic at a High-volume Radiation Oncology Proton Center in New York City |pdf=|usr=}}
 +
{{tp|p=32219627|t=ä. Development Path and Urgency of further Strengthening Construction of Public Hospitals Based on Novel Coronavirus Pneumonia Treatment |pdf=|usr=}}
 +
{{tp|p=32219625|t=ä. Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection |pdf=|usr=}}
 +
{{tp|p=C7114953|t=ä. Telemental Health in the Context of a Pandemic: the COVID-19 Experience |pdf=|usr=}}
 +
{{tp|p=32355607|t=ä. What Does the COVID-19 Pandemic Mean for Rheumatology Patients?|pdf=|usr=}}
 +
 +
 +
  
 
*'''[[Mental aspects of health professionals]]'''
 
*'''[[Mental aspects of health professionals]]'''
Zeile 236: Zeile 287:
 
{{tp|p=32357996|t=2020. Health care practitioners  responsibility to address intimate partner violence related to the COVID-19 pandemic |pdf=|usr=}}
 
{{tp|p=32357996|t=2020. Health care practitioners  responsibility to address intimate partner violence related to the COVID-19 pandemic |pdf=|usr=}}
 
{{tp|p=32299225|t=2020. Physical Distancing and Emotional Closeness Amidst COVID-19 |pdf=|usr=}}
 
{{tp|p=32299225|t=2020. Physical Distancing and Emotional Closeness Amidst COVID-19 |pdf=|usr=}}
 
+
{{tp|p=32337131|t=ä. Focus on Mental Health During the Coronavirus (COVID-19) Pandemic: Applying Learnings from the Past Outbreaks |pdf=|usr=}}
 +
{{tp|p=32328363|t=ä. The Unaddressed Behavioral Health Aspect During the Coronavirus Pandemic |pdf=|usr=}}
 +
{{tp|p=C7147210|t=ä. Effects of COVID 19 pandemic in daily life |pdf=|usr=}}
  
  
Zeile 246: Zeile 299:
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
 
*'''[[Origin of Covid19]]'''
 
*'''[[Origin of Covid19]]'''
 +
 +
{{tp|p=32315626|t=2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak |pdf=|usr=}}
 +
  
 
*'''[[Remission, recurrence and persistence]]'''
 
*'''[[Remission, recurrence and persistence]]'''
Zeile 253: Zeile 309:
 
{{tp|p=32360448|t=ä. SARS-CoV-2 positivity in a discharged COVID-19 patient: A Case report |pdf=|usr=}}
 
{{tp|p=32360448|t=ä. SARS-CoV-2 positivity in a discharged COVID-19 patient: A Case report |pdf=|usr=}}
 
{{tp|p=32304746|t=ä. A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs |pdf=|usr=}}
 
{{tp|p=32304746|t=ä. A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs |pdf=|usr=}}
 +
{{tp|p=32299477|t=2020. A case of a readmitted patient who recovered from COVID-19 in Chengdu, China |pdf=|usr=}}
 +
  
 
*'''[[Epidemiology]]'''
 
*'''[[Epidemiology]]'''
Zeile 265: Zeile 323:
 
{{tp|p=32355435|t=ä. Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections  The case of China |pdf=|usr=}}
 
{{tp|p=32355435|t=ä. Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections  The case of China |pdf=|usr=}}
 
{{tp|p=32220236|t=2020. Familial cluster of COVID-19 infection from an asymptomatic |pdf=|usr=}}
 
{{tp|p=32220236|t=2020. Familial cluster of COVID-19 infection from an asymptomatic |pdf=|usr=}}
 
+
{{tp|p=C7155160|t=2020. The model of epidemic (COVID-19) prevention and control in rural of China |pdf=|usr=}}
 
+
{{tp|p=32351831|t=ä. Perspective from Ecuador, the Second Country with More Confirmed Cases of Coronavirus Disease 2019 in South America: A Review |pdf=|usr=}}
 +
{{tp|p=32211279|t=ä. An Ounce of Prevention: Coronavirus (COVID-19) and Mass Gatherings |pdf=|usr=}}
 +
{{tp|p=32313754|t=ä. An Epidemiological Study on COVID-19: A Rapidly Spreading Disease |pdf=|usr=}}
 +
{{tp|p=32313784|t=ä. Changes in Subway Ridership in Response to COVID-19 in Seoul, South Korea: Implications for Social Distancing |pdf=|usr=}}
 +
{{tp|p=32132379|t=2020. The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and  the persistent threat of respiratory tract infectious diseases to global health security |pdf=|usr=}}
 +
{{tp|p=32187818|t=2020. The Cholera Epidemics in Hamburg and What to Learn for COVID?19 (SARS?CoV?2) |pdf=|usr=}}
  
 
*'''[[Failure of politics and public health guidance]]'''
 
*'''[[Failure of politics and public health guidance]]'''
Zeile 274: Zeile 337:
 
*'''[[Failure of executive measures]]'''
 
*'''[[Failure of executive measures]]'''
 
*'''[[Political abuse of Covid19]]'''
 
*'''[[Political abuse of Covid19]]'''
 +
{{tp|p=C7152572|t=ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter |pdf=|usr=}}
 +
 
*'''[[Lost people]]'''
 
*'''[[Lost people]]'''
 
*'''[[Lost civilization]]'''
 
*'''[[Lost civilization]]'''
Zeile 289: Zeile 354:
 
{{tp|p=32336678|t=2020. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic |pdf=|usr=}}
 
{{tp|p=32336678|t=2020. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic |pdf=|usr=}}
 
{{tp|p=32362721|t=ä. Cyberpsychology research and COVID-19 |pdf=|usr=}}
 
{{tp|p=32362721|t=ä. Cyberpsychology research and COVID-19 |pdf=|usr=}}
 
+
{{tp|p=32303245|t=2020. The application of strong matrix management and PDCA cycle in the management of severe COVID-19 patients |pdf=|usr=}}
 
{{tp|p=32178711|t=2020. Treatment of COVID-19: old tricks for new challenges |pdf=|usr=}}
 
{{tp|p=32178711|t=2020. Treatment of COVID-19: old tricks for new challenges |pdf=|usr=}}
 +
{{tp|p=32282268|t=2020. Emergence of Novel Coronavirus and COVID-19: whether to stay or die out?|pdf=|usr=}}
 +
{{tp|p=32328378|t=ä. Understanding the Mosaic of COVID-19: A Review of the Ongoing Crisis |pdf=|usr=}}
 +
{{tp|p=32337139|t=ä. Searching an Effective Therapy for the Coronavirus Pandemic: Do We See Light at the End of the Tunnel?|pdf=|usr=}}
 +
{{tp|p=32328369|t=ä. A Bibliometric Analysis of COVID-19 Research Activity: A Call for Increased Output |pdf=|usr=}}
 +
{{tp|p=32313804|t=ä. Tracing New Clinical Manifestations in Patients with COVID-19 in Chile and Its Potential Relationship with the SARS-CoV-2 Divergence |pdf=|usr=}}
 +
 +
 +
*'''[[from the ads]]'''
 +
*[http://www.okaybio.com covid19 antibodies, proteins & reagents]

Version vom 20. Mai 2020, 16:33 Uhr


32337143 ä. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
32337113 ä. Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2
32328367 ä. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment
32300496 ä. Coronavirus Disease: A Review of a New Threat to Public Health
32269893 ä. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19)
32363221 ä. An overview of coronaviruses including the SARS-2 coronavirus ? Molecular biology, epidemiology and clinical implications


32142596 2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS
32187834 2020. ..COVID19: Cytometry and the New Challenge for Global Health


32311462 2020. On the molecular determinants of the SARS-CoV-2 attack
32129843 ä. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients
32129842 ä. A glimpse into the origins of genetic diversity in SARS-CoV-2
32229288 ä. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy



32220422 2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections


32271376 ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19


32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32333860 2020. Presepsin in risk stratification of SARS-CoV-2 patients
32161940 ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China
32280952 ä. Good IgA bad IgG in SARS-CoV-2 infection?
32354367 2020. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia



32358954 ä. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing
32361747 ä. COVID-19, superinfections and antimicrobial development: What can we expect?
32188484 2020. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan
32345311 2020. Clinical determinants for fatality of 44,672 patients with COVID-19



32173725 ä. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
32161968 ä. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias
32271373 ä. Predictors of refractory Coronavirus disease (COVID-19) pneumonia
32375845 2020. Acute respiratory failure in COVID-19: is it ?typical? ARDS?
32299472 2020. COVID-19 pneumonia: ARDS or not?
32351860 ä. Coronavirus Disease 2019 (COVID-19) Complicated by Acute Respiratory Distress Syndrome: An Internist?s Perspective



32250159 2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients
32357997 2020. Coagulopathy associated with COVID-19


32178975 ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis


32371557 2020. SARS-CoV-2 and myocardial injury: Few answers, many questions
32331780 ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging
32318865 2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response



32357210 ä. Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19)
32215618 ä. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
32323704 2020. COVID-19 emergency in the cruise s ship: a case report of conjunctivitis
32266761 2020. Neurological manifestations in COVID19 caused by SARS-CoV?2
32354654 ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic
32328364 ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy



32371006 ä. Diarrhea: An underestimated symptom in Coronavirus disease 2019
32360055 ä. Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic
32305249 ä. A case of COVID-19 patient with the diarrhea as initial symptom and literature review
32366282 2020. Liver injury in critically ill patients with COVID-19: a case series
32351807 ä. Gastrointestinal Infection Could Be New Focus for Coronavirus Diagnosis


32299479 2020. Acute kidney injury in SARS-CoV-2 infected patients


32215622 ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility


32326952 2020. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression
32313785 ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19


32327229 2020. CT characteristics of patients infected with 2019 novel coronavirus: association with clinical type
32331781 ä. Ultrasound in COVID-19: a timeline of ultrasound findings in relation to CT
32355659 ä. The role of 18F-FDG PET for COVID-19 infection: myth versus reality
32295762 2020. Chest CT imaging of an early Canadian case of COVID-19 in a 28-year-old man
32312827 2020. Lung ultrasonography in a woman with COVID-19: This examination could be remote
32375883 2020. Can computed tomography be a primary tool for COVID-19 detection? Evidence appraisal through meta-analysis
32234724 2020. Lung ultrasound findings in a 64-year-old woman with COVID-19
32345353 2020. Lung ultrasound findings in patients with COVID-19 pneumonia
32351814 ä. Common CT Findings of Novel Coronavirus Disease 2019 (COVID-19): A Case Series
32305134 ä. Chest Imaging in Patients Hospitalized With COVID-19 Infection - A Case Series


32276598 2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia


32360444 ä. Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of anti-infective therapy (SITA) and the Italian Society of Pulmonology (SIP)
32216962 2020. An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement
32344166 ä. COVID-19 pandemic?a focused review for clinicians
32216961 2020. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area
32321645 ä. The continuing evolution of COVID-19 imaging pathways in the UK: a British Society of Thoracic Imaging expert reference group update
32328954 ä. Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice
32321116 2020. COVID-19 Diagnostic and Management Protocol for Pediatric Patients
32350002 2020. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline
32312828 2020. Clarifying the role of lung ultrasonography in COVID-19 respiratory disease
32375855 2020. Ethics guidelines on COVID-19 triage?an emerging international consensus
32234064 2020. Covid-19 in China: ten critical issues for intensive care medicine
32188482 2020. COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China
32151274 2020. Preparing for COVID-19: early experience from an intensive care unit in Singapore
32224769 2020. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
32257728 ä. Coronavirus Disease (COVID-19) and Pediatric Patients: A Review of Epidemiology, Symptomatology, Laboratory and Imaging Results to Guide the Development of a Management Algorithm



32371555 2020. Utility of extracorporeal membrane oxygenation in COVID-19
32357995 2020. Tracheal intubation in patients with COVID-19
32326959 2020. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients
C7156900 2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series



32304745 ä. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China
32161990 ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
32328736 ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
32376643 2020. Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women
32332039 2020. Renin-angiotensin-aldosterone system inhibitors and COVID-19
32357998 2020. Cardiac considerations in patients with COVID-19
32332038 2020. Asthma and COVID-19
32264922 2020. COVID-19 and the RAAS?a potential role for angiotensin II?
32291526 2020. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
32350632 2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty
32219626 ä. Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital, China



32147731 ä. Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS
32227197 ä. A Community Transmitted Case of Severe Acute Respiratory Distress Syndrome due to SARS CoV2 in the United States
32211789 ä. The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area
32240285 ä. First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States ? Maricopa County, Arizona, 2020
32332041 2020. SARS-CoV-2 infection in a 76-year-old man with negative results for nasopharyngeal swabs and possible nosocomial transmission
32317275 2020. SARS-CoV-2 infection associated with spontaneous pneumothorax
32337148 ä. Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction



32251842 ä. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital
32359867 ä. Impact of gender on extent of lung injury in COVID-19
32362344 ä. Association between clinical manifestations and prognosis in patients with COVID-19
32078069 2020. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies
32375850 2020. Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan
32354360 2020. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China
32232652 ä. Clinical and Transmission Characteristics of Covid-19 ? A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department
32207032 ä. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China


32344167 ä. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study
32305181 ä. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection
32360083 ä. Modulation of Hb-O2 affinity to improve hypoxemia in COVID-19 patients
32306288 ä. Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
32277367 ä. Rheumatologists? perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
32373721 2020. Low dose lung radiotherapy for COVID-19 pneumonia The rationale for a cost-effective anti-inflammatory treatment
32269021 2020. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
32209231 2020. Computers and viral diseases Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus
32264963 2020. A new clinical trial to test high-dose vitamin C in patients with COVID-19
32280433 ä. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
32345336 2020. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
32351851 ä. A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine
32241301 2020. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
32226695 ä. Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19)
32318324 ä. Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival
32340837 ä. Hydroxychloroquine in Covid-19: Does the end justify the means?
32219057 ä. The SARS-CoV-2 Vaccine Pipeline: an Overview
32360420 ä. Cytokine storm intervention in the early stages of COVID-19 pneumonia



32241022 ä. SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection
32297915 ä. Comment of the potential risks of sexual and vertical transmission of Covid-19 infection



32315026 ä. Responding to the COVID-19 outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems
32166318 ä. Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak ?Lessons from Taiwan s SARS response
32354653 ä. COVID-19 Pandemic: Survey of future use of personal protective equipment in optometric practice



32371561 2020. Pulmonary function testing precautions in a time of COVID-19
32371560 2020. PAP therapy increases the risk of transmission of COVID-19
32252508 2020. Sharing Our Experience of Operating an Endoscopy Unit in the Midst of a COVID-19 Outbreak
32371164 ä. RECOMMENDATIONS FOR ESSENTIAL ESOPHAGEAL PHYSIOLOGICTESTING DURING THE COVID-19 PANDEMIC
32304737 ä. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic
32166310 ä. A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2)
32278082 ä. Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre
32330569 ä. Clinical microbiology laboratory adaptation to COVID-19 emergency: experience at a large teaching hospital in Rome, Italy
32312609 ä. Full Spectrum of Cancer Patients in SARS-CoV-2 Infection Still Being Described
32299723 ä. Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic
32362444 ä. Lymphocytopenia and Radiotherapy Treatment Volumes in the Time of COVID-19
32359847 ä. Challenges and Consequences of COVID-19 in the Management of Anorectal Cancer: Coming Together Through Social Distancing
32354668 ä. Effect of COVID-19 pandemic on cancer clinician decision making: Known knowns and known unknowns
32359846 2020. Managing the COVID-19 Pandemic as a National Radiation Oncology Centre in Singapore
32246280 ä. Health services provision of 48 public tertiary dental hospitals during the COVID-19 epidemic in China
32078048 ä. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis
32265036 2020. A British Society of Thoracic Imaging statement: considerations in designing local imaging diagnostic algorithms for the COVID-19 pandemic
32291080 ä. Planning and coordination of the radiological response to the coronavirus disease 2019 (COVID-19) pandemic: the Singapore experience
32299617 2020. Respirators and surgical facemasks for COVID-19: implications for MRI
32235170 ä. Triaging Spine Surgery in the COVID-19 Era
32274425 2020. COVID-19: Global radiation oncology?s targeted response for pandemic preparedness
32321117 2020. Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
32294673 2020. How should health systems prepare for the evolving COVID-19 pandemic? Reflections from the perspective of a Tertiary Cancer Center
32376644 2020. Confronting the COVID-19 surgery crisis: time for transformational change
32152059 2020. Proposed protocol to keep COVID-19 out of hospitals
32269020 2020. Projecting demand for critical care beds during COVID-19 outbreaks in Canada
32317277 2020. Redesign of a rural emergency department to prepare for the COVID-19 pandemic
32336679 2020. Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions
32273245 ä. The COVID-19 pandemic: Important considerations for contact lens practitioners
32359967 ä. Increased risk of ocular injury seen during lockdown due to COVID-19
32336578 ä. Could telehealth help eye care practitioners adapt contact lens services during the COVID-19 pandemic?
32272172 2020. Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?
32334933 ä. Contact lens wear during the COVID-19 pandemic
32305289 ä. No-Test Medication Abortion: A Sample Protocol for Increasing Access During a Pandemic and Beyond???
32183864 2020. Safe patient transport for COVID-19
32070391 2020. Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China
32264974 2020. Practice of novel method of bedside postpyloric tube placement in patients with coronavirus disease 2019
32345337 2020. Is a more aggressive COVID-19 case detection approach mitigating the burden on ICUs? Some reflections from Italy
32345343 2020. COVID-19: ICU delirium management during SARS-CoV-2 pandemic
32345359 2020. The role of telemedicine during the COVID-19 epidemic in China?experience from Shandong province
32321566 2020. Managing COVID-19 in resource-limited settings: critical care considerations
32229766 2020. COVID-19 Pandemic and Acute Myocardial Infarction: Management Protocol From a British Cardiac Centre
32349045 2020. COVID-19 Pandemic and Cardiac Electrophysiology: Guidance Protocol From a UK Tertiary Cardiac Center
C7155152 2020. How to transform a general hospital into an ?infectious disease hospital? during the epidemic of COVID-19
32321562 2020. Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic
32324622 2020. Restructuring Electrophysiology During the COVID-19 Pandemic: A Practical Guide From a New York City Hospital Network
32344317 ä. Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
32368424 ä. The Impact of COVID-19 on Medical Education
32368429 ä. Quantifying the Impact of COVID-19 on Cancer Patients: A Technical Report of Patient Experience During the COVID-19 Pandemic at a High-volume Radiation Oncology Proton Center in New York City
32219627 ä. Development Path and Urgency of further Strengthening Construction of Public Hospitals Based on Novel Coronavirus Pneumonia Treatment
32219625 ä. Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection
C7114953 ä. Telemental Health in the Context of a Pandemic: the COVID-19 Experience
32355607 ä. What Does the COVID-19 Pandemic Mean for Rheumatology Patients?




32246142 ä. Care for the psychological status of frontline medical staff fighting against COVID-19
32339218 ä. Working schedule, sleep quality and susceptibility to COVID-19 in healthcare workers
32295761 2020. Mitigating the psychological effects of COVID-19 on health care workers
32375848 2020. Psychological stress of ICU nurses in the time of COVID-19
32220243 2020. Special attention to nurses? protection during the COVID-19 epidemic



32371559 2020. Helping children cope with the COVID-19 pandemic
32357996 2020. Health care practitioners responsibility to address intimate partner violence related to the COVID-19 pandemic
32299225 2020. Physical Distancing and Emotional Closeness Amidst COVID-19
32337131 ä. Focus on Mental Health During the Coronavirus (COVID-19) Pandemic: Applying Learnings from the Past Outbreaks
32328363 ä. The Unaddressed Behavioral Health Aspect During the Coronavirus Pandemic
C7147210 ä. Effects of COVID 19 pandemic in daily life



32315626 2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak



32311512 ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19
32266381 ä. PCR Assays Turned Positive in 25 Discharged COVID-19 Patients
32302000 ä. The duration of viral shedding of discharged patients with severe COVID-19
32360448 ä. SARS-CoV-2 positivity in a discharged COVID-19 patient: A Case report
32304746 ä. A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs
32299477 2020. A case of a readmitted patient who recovered from COVID-19 in Chengdu, China



32344169 ä. A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection
32344168 ä. Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea
32354669 ä. COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy
32331805 ä. Echoes of 2009 H1N1 Influenza Pandemic in the COVID Pandemic
32144097 2020. What can early Canadian experience screening for COVID-19 teach us about how to prepare for a pandemic?
32269019 2020. Social distancing to combat COVID-19: We are all on the front line
32332040 2020. What can countries learn from Hong Kong s response to the COVID-19 pandemic?
32269018 2020. Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada
32355435 ä. Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections The case of China
32220236 2020. Familial cluster of COVID-19 infection from an asymptomatic
C7155160 2020. The model of epidemic (COVID-19) prevention and control in rural of China
32351831 ä. Perspective from Ecuador, the Second Country with More Confirmed Cases of Coronavirus Disease 2019 in South America: A Review
32211279 ä. An Ounce of Prevention: Coronavirus (COVID-19) and Mass Gatherings
32313754 ä. An Epidemiological Study on COVID-19: A Rapidly Spreading Disease
32313784 ä. Changes in Subway Ridership in Response to COVID-19 in Seoul, South Korea: Implications for Social Distancing
32132379 2020. The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security
32187818 2020. The Cholera Epidemics in Hamburg and What to Learn for COVID?19 (SARS?CoV?2)


32246996 ä. The SARS-CoV-2 epidemic: how the Italian public is being informed
32292239 2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis


C7152572 ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter


32296817 ä. Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials
32360446 2020. COVID-19: don t neglect antimicrobial stewardship principles!
32058086 2020. Novel coronavirus: how things are in Wuhan
32366470 2020. Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection
32184199 2020. Working together to contain and manage COVID-19
32312831 2020. Who should wear a face mask? Experts weigh in on Canada s COVID-19 response
32336678 2020. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic
32362721 ä. Cyberpsychology research and COVID-19
32303245 2020. The application of strong matrix management and PDCA cycle in the management of severe COVID-19 patients
32178711 2020. Treatment of COVID-19: old tricks for new challenges
32282268 2020. Emergence of Novel Coronavirus and COVID-19: whether to stay or die out?
32328378 ä. Understanding the Mosaic of COVID-19: A Review of the Ongoing Crisis
32337139 ä. Searching an Effective Therapy for the Coronavirus Pandemic: Do We See Light at the End of the Tunnel?
32328369 ä. A Bibliometric Analysis of COVID-19 Research Activity: A Call for Increased Output
32313804 ä. Tracing New Clinical Manifestations in Patients with COVID-19 in Chile and Its Potential Relationship with the SARS-CoV-2 Divergence


Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis